|
|
Article: Patent No. 7,572,772 Issued on Aug. 11, Assigned to Bristol-Myers Squibb for Soluble Mutant Molecule (Washington, New Jersey Inventors)
- Article from:
- US Fed News Service, Including US State News
- Article date:
- August 17, 2009
CopyrightCopyright © HT Media Ltd. All Rights Reserved. Provided by ProQuest LLC. (Hide copyright information)
|
ALEXANDRIA, Va., Aug. 17 -- Peter S. Linsley, Jeffrey A. Ledbetter and Philip M. Wallace, all from Seattle, Nitin K. Damle of Upper Saddle River, New Jersey, and William Brady of Bothell, Wash., have developed a soluble mutant molecule. The inventors were issued U.S. Patent No. 7,572,772 on Aug. 11.
The patent has been assigned to Bristol-Myers Squibb Co., Princeton, N.J.
According to the abstract released by the U.S. Patent & Trademark Office: "The ...
Related newspaper, magazine, and journal articles:
|
|
Article: ECONOMIC RECOVERY PACKAGE IMPACT ON NEW JERSEY: ...
US Fed News Service, Including US State News;
February 13, 2009 ;
700+ words
... ... Bringing the State of New Jersey $2.22 billion for Medicaid ... higher than the amount New Jersey would have received in ... would have further lowered New Jersey's allocation of these ... more information about US Fed News contract awards please ...
|
|